AdvisorNet Financial, Inc
Position in REGN — Regeneron Pharmaceuticals, Inc.
CIK 1409362
MINNETONKA, MN
Position in REGN
as of Mar 31, 2026
· filed Apr 17, 2026
Position Value
$104,306
+$64,169 QoQ
Shares Held
135
+159.6% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026AdvisorNet Financial, Inc holds $2,790,551 across 42 Biotechnology names. REGN ranks #5 (3.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,864 | $1,278,890 | |
| 2 | CRSP |
CRISPR Therapeutics AG
|
8,003 | $380,702 | |
| 3 | INCY |
Incyte Corp
|
3,132 | $294,783 | |
| 4 | TECH |
BIO-TECHNE Corp
|
4,055 | $211,914 | |
| 5 | REGN |
Regeneron Pharmaceuticals, Inc.
This page
|
135 | $104,306 | |
| 6 | NAMS |
NewAmsterdam Pharma Co N.V.
|
2,565 | $82,105 | |
| 7 | TGTX |
Tg Therapeutics, Inc.
|
1,620 | $53,816 | |
| 8 | KRYS |
Krystal Biotech, Inc.
|
171 | $44,172 |
All Filings in REGN
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $104,306 | 135 | Shares | Sole | 2026-04-17 | |
| 2025-12-31 | $40,137 | 52 | Shares | Sole | 2026-01-20 | |
| 2025-09-30 | $34,860 | 62 | Shares | Sole | 2025-10-09 | |
| 2025-06-30 | $32,025 | 61 | Shares | Sole | 2025-07-14 | |
| 2025-03-31 | $47,567 | 75 | Shares | Sole | 2025-04-07 | |
| 2024-12-31 | $55,561 | 78 | Shares | Sole | 2025-01-13 | |
| 2024-09-30 | $105,124 | 100 | Shares | Sole | 2024-10-15 | |
| 2024-06-30 | $72,521 | 69 | Shares | Sole | 2024-07-16 | |
| 2024-03-31 | $66,411 | 69 | Shares | Sole | 2024-04-12 | |
| 2023-12-31 | $90,463 | 103 | Shares | Sole | 2024-01-19 | |
| 2023-09-30 | $101,224 | 123 | Shares | Sole | 2023-10-12 | |
| 2023-06-30 | $175,323 | 244 | Shares | Sole | 2023-07-14 | |
| 2023-03-31 | $210,347 | 256 | Shares | Sole | 2023-04-28 | |
| 2022-12-31 | $183,979 | 255 | Shares | Sole | 2023-01-13 | |
| 2022-09-30 | $161,195 | 234 | Shares | Sole | 2022-10-04 | |
| 2022-06-30 | $141,280 | 239 | Shares | Sole | 2022-07-07 | |
| 2022-03-31 | $81,715 | 117 | Shares | Sole | 2022-04-14 | |
| 2021-12-31 | $82,097 | 130 | Shares | Sole | 2022-01-19 | |
| 2021-09-30 | $77,463 | 128 | Shares | Sole | 2021-10-15 | |
| 2021-06-30 | $70,934 | 127 | Shares | Sole | 2021-07-06 | |
| 2021-03-31 | $68,132 | 144 | Shares | Sole | 2021-04-14 | |
| 2020-12-31 | $77,297 | 160 | Shares | Sole | 2021-02-04 | |
| 2020-09-30 | $112,515 | 201 | Shares | Sole | 2020-11-06 | |
| 2020-06-30 | $109,762 | 176 | Shares | Sole | 2020-08-26 | |
| 2020-03-31 | $49,317 | 101 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||